ϩ intake) elevations in circulating aldosterone (ALDO), termed aldosteronism, are associated with remodeling of intramural arteries of the right and left heart. Lesions appear at week 4 of treatment with ALDO and 1% dietary NaCl in uninephrectomized rats (ALDOST) and include invading monocytes, macrophages and lymphocytes with intracellular evidence of oxidative and nitrosative stress, myofibroblasts, and perivascular fibrosis. In this study, we tested the hypothesis that an immunostimulatory state with activated circulating peripheral blood mononuclear cells (PBMCs) precedes this proinflammatory and profibrogenic cardiac phenotype and is initiated by reduction in the cytosolic free Mg 2ϩ concentration ([Mg 2ϩ ]i). At 1 and 4 wk of ALDOST (preclinical and clinical stages, respectively), we monitored serum Mg 2ϩ , PBMC [Mg 2ϩ ]i and cytosolic free [Ca 2ϩ ] (via fluorimetry), and expressed genes (via microchip array) as well as markers of oxidative and nitrosative stress in plasma [␣ 1 -antiproteinase activity (␣ 1 -AP)] and cardiac tissue (immunohistochemical detection of gp91 phox subunit of NADPH oxidase and 3-nitrotyrosine). Age-and gender-matched unoperated and untreated (UO) rats and uninephrectomized salt-treated (UN) rats served as controls. Serum [Mg 2ϩ ] was unchanged by ALDOST. In contrast with UO and UN, [Mg 2ϩ ]i and plasma ␣1-AP were each reduced (P Ͻ 0.05) at weeks 1 and 4. The decline in PBMC [Mg 2ϩ ]i was accompanied by Ca 2ϩ loading. Differential (twofold and higher) expression (up-and downregulation) in PBMC transcriptomes was present at week 1 and progressed at week 4. Involved were genes for the ␣ 1-isoform of Na ϩ -K ϩ -ATPase, the ATPdependent Ca 2ϩ pump, antioxidant reserves, inducible nitric oxide synthase, and PBMC activation with autoimmune responses. Expression of 3-nitrotyrosine and activation of gp91 phox were seen in inflammatory cells that invaded intramural arteries. Thus early in aldosteronism (preclinical stage), an immunostimulatory state featuring activated circulating PBMCs with reduced ionized [Mg 2ϩ ]i and oxidative and nitrosative stress precedes and may even predispose to coronary vascular lesions that first appear at week 4. peripheral blood mononuclear cells; ionized magnesium; oxidative and nitrosative stress; transcriptome; pathology IN BOTH HUMANS AND RATS and whether derived from endogenous or exogenous sources, chronic inappropriate (relative to dietary Na ϩ intake) elevations in circulating aldosterone (ALDO) are associated with structural remodeling of intramural arteries of the right and left heart and systemic organs (9, 14, 15, 27, 39, 45, 52, 53, 63, 66, 75) . Coronary vascular lesions in uninephrectomized rats first appear at 4 wk of ALDO-andsalt treatment (ALDOST) and involve progressively more vascular sites with continued treatment (64). Lesions consist of circulating monocytes, macrophages and lymphocytes that have invaded the perivascular space; fibroblastlike cells or myofibroblasts that express fibrillar type I and III collagens; and ultimately a perivascular fibrosis (15, 27, 39, 45, 52, 53, 64) . Sun et al. (65) addressed cellular and molecular events that are involved in the appearance of this proinflammatory and profibrogenic cardiac phenotype. When studied using immunohistochemistry, oxidative and nitrosative stress appeared within inflammatory cells that had invaded the coronary vasculature together with activation of the redox-sensitive nuclear transcription factor NF-B and upregulated mRNA expression of a proinflammatory mediator cascade that it regulates that includes intercellular adhesion molecule (ICAM)-1, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-␣. Such neurohormonal activation occurs in chronic cardiac failure and is accompanied by increased expression of TNF-family ligands and oxidative stress in peripheral blood mononuclear cells (PBMCs; Refs. 18, 74 
IN BOTH HUMANS AND RATS and whether derived from endogenous or exogenous sources, chronic inappropriate (relative to dietary Na ϩ intake) elevations in circulating aldosterone (ALDO) are associated with structural remodeling of intramural arteries of the right and left heart and systemic organs (9, 14, 15, 27, 39, 45, 52, 53, 63, 66, 75) . Coronary vascular lesions in uninephrectomized rats first appear at 4 wk of ALDO-andsalt treatment (ALDOST) and involve progressively more vascular sites with continued treatment (64) . Lesions consist of circulating monocytes, macrophages and lymphocytes that have invaded the perivascular space; fibroblastlike cells or myofibroblasts that express fibrillar type I and III collagens; and ultimately a perivascular fibrosis (15, 27, 39, 45, 52, 53, 64) . Sun et al. (65) addressed cellular and molecular events that are involved in the appearance of this proinflammatory and profibrogenic cardiac phenotype. When studied using immunohistochemistry, oxidative and nitrosative stress appeared within inflammatory cells that had invaded the coronary vasculature together with activation of the redox-sensitive nuclear transcription factor NF-B and upregulated mRNA expression of a proinflammatory mediator cascade that it regulates that includes intercellular adhesion molecule (ICAM)-1, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-␣. Such neurohormonal activation occurs in chronic cardiac failure and is accompanied by increased expression of TNF-family ligands and oxidative stress in peripheral blood mononuclear cells (PBMCs; Refs. 18, 74) . The mechanisms that are responsible for the induction of oxidative and nitrosative stress and activation of PBMCs in aldosteronism are unclear.
Mg 2ϩ is involved in myriad reactions and functions in various cells including PBMCs. These include enzymatic reactions, operation of channels, receptors, and intracellular signaling molecules, and conformation of nucleic acids and proteins (22, 50, 54, 55) . ALDO influences Mg 2ϩ homeostasis, including increased urinary Mg 2ϩ excretion and reduced PBMC ionized Mg 2ϩ levels (20, 30) . In this study, we investigated the hypothesis that an immunostimulatory state with activated circulating PBMCs precedes the proinflammatory and profibrogenic cardiac phenotype in aldosteronism and is induced by a reduction in the cytosolic Mg 2ϩ concentration ([Mg 2ϩ ] i ). Toward this end, we monitored the PBMC transcriptome or the genes that it expresses together with markers of oxidative and nitrosative stress in plasma and invading inflammatory cells, and levels of PBMC [Mg 2ϩ ] i and cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] i ) at 1 and 4 wk of ALDOST; these represent the preclinical and clinical stages of aldosteronism, respectively.
MATERIALS AND METHODS
Animals. Eight-week-old male Sprague-Dawley rats (Harlan) were used. The study was approved by the institution's Animal Care and Use Committee. Unoperated and untreated (UO) age-matched rats served as one control group (n ϭ 5). Uninephrectomized rats that received 1% NaCl/0.4% KCl in drinking water and standard laboratory feed served as a second control group (n ϭ 10). Separate groups of uninephrectomized salt-treated (UN) rats received ALDO (0.75 g/h) via implanted minipump for 1 or 4 wk (n ϭ 10 at each time point). This dose of ALDO promptly raises plasma levels to those seen in humans with congestive heart failure or primary aldosteronism (PAL); it also rapidly suppresses plasma renin activity and circulating angiotensin II levels (9, 24) . Animals were observed daily to monitor physical activity and food and water consumption. Systolic blood pressure was recorded as previously reported (65) . At the conclusion of wk 1 or 4 of ALDOST, animals were weighed and anesthetized, blood was obtained by cardiac puncture, and hearts were harvested.
Plasma Mg 2ϩ concentrations. Total Mg 2ϩ concentrations in 1:20-fold diluted plasma were determined in 100-l specimens using a Varian model 220 FS double-beam fast sequential atomic absorption spectrophotometer (Varian Techtron; Melbourne, Australia) and were expressed in milligrams per deciliter (5) .
[ 6 cells each) were suspended in RPMI 1640 and 0.1% BSA (vol/vol) with the cell-permeant dye mag-fura 2-acetoxymethyl ester (mag-fura 2-AM, 10 mol/l; Molecular Probes; Eugene, OR) and incubated for 1 h at 37°C. After centrifugation, cells were washed twice with RPMI 1640 and 0.1% BSA for removal of extracellular dye and were resuspended in the same medium. Cells were incubated for an additional 45 min at room temperature to allow complete deesterification of the intracellular dye. The cells were then centrifuged and suspended in 2 ml of buffer [that contained (in mmol/l) 140 NaCl, 5 KCl, 1.8 CaCl 2, 0.8 MgSO4, 15 HEPES, and 5 D-glucose (pH 7.4)], transferred to a quartz cuvette, and measured fluorimetrically using a spectrofluorometer (model LS-50B, Perkin-Elmer). Fluorescence emission at 510 nm (slit width, 5 nm) was measured at alternate excitations of 335 and 370 nm (slit width, 10 nm). After initial fluorescence was measured, 5 mmol/l each of EDTA and EGTA were added to the cuvette to chelate extracellular Mg 2ϩ , and fluorescence values at 335 and 370 nm were read again for calculation of the free resting [Mg 2ϩ ]i ratio (R). Triton X-100 was then added at a final concentration of 0.1% to lyse the cells, and fluorescence values at 335 and 370 nm were read again for calculation of the minimum fluorescence ratio (R min). Subsequently MgSO4 (100 mmol/l) was added to the cuvette, and the fluorescence values at 335 and 370 nm were read for calculation of the maximum fluorescence ratio (R max). [Mg 2ϩ ]i was then calculated as follows: (26) .
Measurement of plasma ␣1-antiproteinase. Reactive oxygen and nitrogen species generated from oxidative stress inactivate ␣1-antiproteinase (␣1-AP) by oxidizing an essential methionine at positions 1, 8, or 358 of the active-site loop to methionine sulfoxide (8) . Thus the measurement of active ␣1-AP in body fluids is a biomarker used to assess the presence of oxidative and nitrosative stress (19, 25, 46) . Plasma concentrations of ␣1-AP were measured using a commercially available kit (Oxis Research; Portland, OR). Briefly, plasma was diluted 1:50 with Tris ⅐ HCl-phosphate buffer (pH 8.0). Diluted plasma (50 l) or assay buffer (for controls) was added to a test tube that contained buffer (500 l) and 2 M elastase (50 l) in assay buffer. The tubes were incubated at 37°C for 5 min and subsequently incubated at room temperature for 5 min. This method is based on the measurement of elastase activity and cleavage of N-succinyl-(Ala)3-p-nitroanilide (NASAN), which results in the production of the chromagen p-nitroaniline. Thus the substrate solution NASAN (400 l) was added to the tube, mixed by vortexing, and immediately transferred to a cuvette. Absorbance values at 410 nm were recorded for at least 1 min to determine the rate of change in absorbance from the slope of the line vs. time (⌬A410). The concentration of ␣1-AP (in M) was then calculated as follows: ␣1-AP ϭ (⌬A410 control Ϫ ⌬A410 sample Ϭ ⌬A410 control) ϫ 2d, where d is the dilution factor of the plasma sample before addition to the assay tube, and the factor 2 represents the elastase concentration (in M). Because ␣1-AP is an irreversible equimolar inhibitor of elastase, the concentration of active ␣1-AP in a sample is equivalent to the concentration of elastase that is inhibited. The intra-and interassay percent coefficients of variability for this assay were Յ6%. The detection limit for this assay was 0.5 M.
PBMC transcriptomes. Total RNA was isolated from purified PBMCs using a tri-reagent (TRIzol, Invitrogen; Carlsbad, CA). Gene-expression analysis was conducted on the Affymetrix rat genome U34A chip (Affymetrix; San Diego, CA) probing ϳ7,000 known genes and 1,000 expressed sequence tags (EST). The gene-expression analysis was conducted by a company that provides this core service for our institution on contract. Detailed protocols and descriptions of analyses are available on their web site (http://www.genomeexplorations.com). Briefly, the quality of total RNA was ensured by analysis using an Agilent Bioanalyzer 2100 "Lab on a Chip" system. RNA was then used to synthesize first-and second-strand cDNA. Double-stranded cDNA was used in an in vitro transcription step to synthesize biotin-labeled cRNA. Transcript quality was assessed again at this step by comparing the 5Ј-to-3Ј ratios of a collection of housekeeping genes. Samples that passed both quality-control steps were hybridized to the expression-array chip and relative expression levels for each probe set (gene or EST) were collected and analyzed using Microarray Suite 5.0 software (Affymetrix). This software was used to normalize the data, evaluate the quality of the data sets, and conduct basic comparisons between data from two samples. Comparative analyses of samples produced a list of differentially expressed genes that are defined as genes with expression levels that are significantly different and at least different by a factor of 1 ϫ log2. A total of six UO controls, six ALDOST samples obtained at 1 wk, and six ALDOST samples obtained at 4 wk went into the characterization of transcriptomes. Each sample that was analyzed on expression-array chips consisted of pooled RNA from three animals. We compared transcriptomes from untreated controls to samples obtained at weeks 1 and 4 of ALDOST to produce a list of genes that are affected by the treatment. The experiment was repeated, and only genes that show differential expression in response to treatment in both of these independent experiments are reported in the lists of specific differentially expressed genes (see Tables 2  and 3) .
Cardiac pathology. Expressions of oxidative and nitrosative stress were studied by immunohistochemical localization of gp91 phox and 3-nitrotyrosine, respectively. Coronal cryostat sections (6 m) were prepared, air dried, fixed in 10% buffered formalin for 5 min, and washed in PBS for 10 min. Sections were then incubated with primary antibody against gp91 phox at a dilution of 1:100 (12) or 3-nitrotyrosine at a dilution of 1:100 (Upstate Biotech; Waltham, MA) in PBS that contained 1% BSA for 60 min. Sections were then washed in PBS for 10 min and incubated with IgG-peroxidase-conjugated secondary antibody (Sigma; St. Louis, MO) at a dilution of 1:150, washed in PBS for 10 min, incubated with 0.5 mg/ml diaminobenzidine tetrahydrochloride 2-hydrate ϩ 0.05% H2O2 for 10 min, and again washed in PBS. Negative control sections were incubated with secondary antibody alone, stained with hematoxylin, dehydrated, mounted, and examined using light microscopy.
Statistical analysis. Plasma Mg 2ϩ , [Mg 2ϩ ]i, [Ca 2ϩ ]i, and ␣1-AP results are expressed as means Ϯ SE. Data were analyzed by ANOVA, and significant differences between groups were determined using the Student-Newman-Keuls multiple-comparisons test. Differences were considered statistically significant when P Ͻ 0.05.
RESULTS

Animals.
During week 1 of ALDOST, animals appeared healthy: they were active, eating, drinking, and gaining body wt (200 Ϯ 5 g, which was not different from body wt of UO and UN control groups, 198 Ϯ 5 and 203 Ϯ 16 g, respectively). After this preclinical stage and at week 4 of ALDOST (clinical stage), animals were lethargic and anorectic and had gained significantly less weight (265 Ϯ 8 g; P Ͻ 0.05) compared with UO and UN controls (345 Ϯ 6 and 340 Ϯ 17 g, respectively). We did not observe aural hyperemia, tetany, or convulsions in ALDOST animals. Systolic blood pressure at week 1 ALDOST was no different from UO (19, 25, 46) and with the generation of oxygen metabolites and peroxynitrite, a product of the reaction of superoxide with nitric oxide (34) . Levels of ␣ 1 -AP (Fig. 3) were no different between UO-and UN-control groups. During preclinical and clinical stages that corresponded to wks 1 and 4 of ALDOST, plasma ␣ 1 -AP values were significantly (P Ͻ 0.05) reduced in keeping with an early and sustained induction of oxidative and nitrosative stress. (Table 1) . A total of 564 genes or ESTs were differentially expressed at one or both times. Of the 72 genes or ESTs that were differentially expressed at weeks 1 and 4, 37 were increased at both times, 30 were decreased at both times (relative to controls), and 5 were differentially expressed in opposite directions at weeks 1 and 4. Whereas 133 of 205 genes and ESTs were uniquely expressed during the preclinical stage at week 1, 359 of 431 genes and ESTs were uniquely expressed at week 4, which suggests that new pathological processes had been initiated.
PBMC transcriptomes.
Within the lists of specific genes that are affected by ALDOST, we found a number of genes with products that are affected by or dependent on cations (Table 2) . For example, the documented decrease in [Mg 2ϩ ] i appears to affect a downregulation of the ␣ 1 -isoform of Na ϩ -K ϩ -ATPase and the corresponding increase in intracellular Ca 2ϩ to affect an upregulation of an ATPdependent Ca 2ϩ pump as well as a number of Ca 2ϩ -dependent genes. Furthermore, we found an upregulation of genes that is associated with producing and counteracting oxidative stress such as inducible nitric oxide synthase (iNOS) and Mn 2ϩ -SOD (Table 3 ). Other indications of inflammatory response activation included increased expression of ICAM-1 as well as chemokines, cytokines, and the associated receptors. Finally, activation of lymphocytes and production of specific immune responses including autoimmune responses were evident (Table 3) .
Cardiac pathology. Microscopic evidence of cardiac pathology involving the invasion of intramural coronary arteries of both ventricles by monocytes, macrophages, and lymphocytes was first seen at week 4 of ALDOST. At these vascular sites (which involve right and left ventricles), immunohistochemical evidence of gp91 phox expression (Fig. 4, A and B) and the presence of 3-nitrotyrosine (Fig. 4, C and D) was found. Cardiac morphology at week 1 ALDOST was no different from controls.
DISCUSSION
Sun et al. (65) have shown that the proinflammatory and profibrogenic cardiac phenotype that involves intramural arteries of the right and left heart in chronic ALDOST rats is related to an induction of oxidative and nitrosative stress and is prevented by antioxidant cotreatment. In this study, we investigated the hypothesis that activation of circulating monocytes, macrophages, and lymphocytes or PBMCs (including the altered redox potential) is related to reduction in [Mg 2ϩ ] i composition. Our study led to several major findings.
First, a reduction in [Mg 2ϩ ] i occurred at week 1 of ALDOST, which is a preclinical stage, before the appearance of systemic illness with anorexia and leth- ] i observed in PBMCs at week 1 ALDOST were significantly reduced compared with age-and gendermatched UO and UN controls. Our control values conform with those reported by others for lymphocytes obtained from rodents on a normal diet (59) . Factors that could have contributed to this decrease in [Mg 2ϩ ] i were considered. We did not monitor urinary or fecal Mg 2ϩ excretion in our rats that received ALDOST; both are increased in patients with PAL and in adrenalectomized rats treated with ALDO (28, 30) and can ultimately lead to hypomagnesemia, which has been reported in several patients with long-standing adrenal adenoma and where normal Mg 2ϩ homeostasis is restored following surgical removal of the adrenal tumor (30, 36, 43) . In the present study, plasma Mg 2ϩ levels at 1 and 4 wks of ALDOST remained within the normal range and were statistically indistinguishable from our two control groups. Dietary Mg 2ϩ deficiency can lead to reduced Mg 2ϩ levels in PBMCs (58, 70, 71 ] i in patients with PAL. We therefore conclude that the reductions in PBMC [Mg 2ϩ ] i that we observed at weeks 1 and 4 in our rat model of aldosteronism are related to an ALDO-mediated Na ϩ -dependent response that likely involves a Na ϩ /Mg 2ϩ exchanger. Previous studies from this laboratory have shown coronary lesions do not appear when ALDO administration is combined with a diet that is deficient in NaCl or with a 1% NaCl diet without ALDO treatment in uninephrectomized controls (10) . Hence, we believe that both ALDO and Na ϩ are needed to drive Mg 2ϩ efflux from PBMCs and initiate the pathogenic inflammatory process. Future in vivo studies that use either an ALDO receptor antagonist or an inhibitor of the Na ϩ /Mg 2ϩ exchanger (56, 61) as cotreatment with ALDOST are planned.
A second major finding of the present study and concordant with the early reduction in [Mg 2ϩ ] i is the activation of the PBMC transcriptome that appears at week 1 of ALDOST, where 205 genes were either up-or downregulated. Mg 2ϩ is an important intracellular divalent cation that is involved in hundreds of enzymatic reactions, many of which are related to ATPases and GTPases. Most Mg 2ϩ is inactive, bound to ATP within the cytosol and within such organelles as endoplasmic reticulum and mitochondria; its relatively small ionized fraction is biologically active. In response to the 8 decrease in [Mg 2ϩ ] i that appears in PBMCs at week 1 ALDOST, we found reduced expression of genes for the ␣ 1 -isoform of Na ϩ -K ϩ -ATPase, ATP-dependent RNA helicase, and cGMP-stimulated phosphodiesterase. Reduced tissue Na ϩ -K ϩ -ATPase activity, which is associated with a Mg 2ϩ -deficient diet in rats and hamsters, is accompanied by an increase in Na ϩ and Ca 2ϩ concentrations in skeletal and cardiac muscle and bone and where the elevation in tissue Ca 2ϩ occurs via a Na ϩ / Ca 2ϩ exchanger (17, 35) . Our data indicate that a similar process may occur in PBMCs. Another factor that could account for a reduction in Na ϩ -K ϩ -ATPase activity in our rat model is an increase in endogenous circulating ouabain, which is a Na ϩ -K ϩ -ATPase inhibitor that is known to accompany PAL and is normalized after surgical removal of adrenal adenoma (57) .
A third major finding of this study was the responses in PBMC [Ca 2ϩ ] i and transcriptome events associated with Ca 2ϩ overload. An accompaniment to reduced Na ϩ -K ϩ -ATPase activity would be an increase in Na ϩ entry followed by the stoichiometric exchange of 3 Na ϩ for 1 Ca 2ϩ via a Na ϩ /Ca 2ϩ exchanger (48) . The influx of Ca 2ϩ contributes to a Ca 2ϩ overload, which initially is shunted to intracellular stores such as mitochondria where an induction of oxidative and nitrosative stress occurs (6, 23, 51, 61) . We found upregulated expression of Mn 2ϩ -SOD, which is specific to mitochondria-based antioxidant reserves (60) . After the saturation of organelles is a subsequent increase in [Ca 2ϩ ] i , which may be facilitated by the decline in [Mg 2ϩ ] i , its physiological antagonist, and nitric oxide-mediated release of Ca 2ϩ from mitochondrial stores (29) . Our analysis of PBMC transcriptomes revealed increased expression of iNOS. Furthermore, Wehling et al. (72) found that ALDO reduces the efflux of [Ca 2ϩ ] i from cultured PBMCs in a Na ϩ -dependent manner inhibited by amiloride. Shifts in intracellular divalent cations are a key component associated with transcriptional activation of many different cell types including lymphocytes (11, 22, 54, 55, 73) . We observed induction of a number of transcripts associated with defenses against free radical production, with the presence of oxidative and nitrosative stress indicated by reduced plasma ␣ 1 -AP and immunohistochemical evidence of gp91 phox expression [an NADPH oxidase subunit that is specific to leukocytes and endothelial cells (60) ] and the presence of 3-nitrotyrosine in PBMCs that invaded the coronary vasculature. For the PBMC transcriptomes, these included expression of antioxidant reserves such as Mn 2ϩ -SOD, glutathione reductase, NADPH oxireductase, and iNOS. Each of these reserves are activated during inflammatory states (33) . In humans and experimental animals, neurohormonal activation is accompanied by induction of oxidative and nitrosative stress in plasma, skeletal muscle, heart, and PMBCs (3, 16, 18, 62, 69, 74) .
Finally, the early activation of specific immune responses in the PBMC transcriptomes that appeared at week 1 of ALDOST was sustained and progressive at week 4, where 230 genes were upregulated, whereas 201 were downregulated. This included induction of inflammatory responses such as ICAM-1, chemokine receptor protein and receptor, IL-1␤ and its receptor, and substance P receptor. Upregulation of ICAM-1 and chemokine receptor genes can stimulate leukocyte movement and migration across the endothelium and media into the perivascular space, where we found immunohistochemical evidence of oxidative and nitrosative stress in inflammatory cells and previously have localized (by in situ hybridization) upregulated mRNA expression of ICAM-1, MCP-1, and TNF-␣ in these cells at sites of cardiac lesions (65) . This immunostimulatory state is further accompanied by upregulation of immunoglobulins, in keeping with B lymphocyte activation, and activation of specific, perhaps autoreactive, immune responses that include upregulation of antiacetylcholine receptor antibody expression and downregulation of RT6 gene, which is depleted in autoimmunity (76) . If specific immune responses were involved in attracting activated PBMCs to the coronary vasculature, this could explain why heart tissue is not affected until week 4 of ALDOST. Autoimmune-mediated injury could contribute to a progressive structural remodeling of the heart and impair its pump function.
Weglicki and coworkers (70, 71) presented evidence of oxidative and nitrosative stress within plasma, reduced antioxidant reserves in PBMCs, elevated PBMC proinflammatory cytokine production, and substance P receptor expression at week 1 of a Mg 2ϩ -deficient diet in rats; these effects preceded cardiac lesions that appeared at week 3, and a substance P receptor antagonist proved to be cardioprotective. Additional evidence linking PBMC behavior and altered immunity with Mg 2ϩ deficiency in adult animals has been reported including exaggerated superoxide production and Ca 2ϩ -mobilizing capacity in response to live bacteria or platelet-activating factors (38) and hyperplasia of bone marrow and thymus (4, 7, 31, 40, 41) . In young weanling rats, cDNA array studies demonstrate that Mg 2ϩ deficiency is accompanied by upregulation of stress protein expression in neutrophils and thymocytes; apoptosis and heat shock proteins in neutrophils (13) ; and cytochrome oxidase, glutathione transferase, SOD, and heat shock proteins in thymocytes (47) .
Heart failure is a major health problem of epidemic proportions. Irrespective of its etiologic origins, a dysfunction of this normally efficient muscular pump during either its ejection or filling phases (i.e., systolic and diastolic dysfunction, respectively) is associated with systemic consequences that lead to a progressive downhill clinical course. Why? Neurohormonal system activation. Sustained release of effector hormones of the renin-angiotensin-ALDO system are maladapative. They not only account for salt and water retention and the congestive heart failure syndrome, they become stressors that invoke a progressive systemic illness. Featured are oxidative and nitrosative stress in PBMCs and plasma (18, 21, 32) ; a "cytokine storm" with elevated plasma levels of proinflammatory cytokines (44, 67, 68); and anorexia, lethargy, and tissue wasting (1). Herein we used a rodent model to address one aspect of the neurohormonal profile of human heart failure, namely, that related to aldosteronism, which is defined as chronic elevation in plasma ALDO that is inappropriate for dietary Na ϩ intake and its association with immune cell activation. During week 1 of ALDOST (a preclinical stage), we found upregulation of the PBMC transcriptomes that featured inflammatory responses and lymphocyte activation. The triggering mechanism associated with this activation was a reduction in PBMC [Mg 2ϩ ] i and was accompanied by upregulation of oxidative and nitrosative stress-related genes and those representing antioxidant reserves. This immunostimulatory state preceded (by weeks) the appearance of clinical illness with lethargy and anorexia and the proinflammatory, profibrogenic cardiac phenotype with coronary vascular lesions. Moreover, autoreactive immune responses were observed that may explain the delayed nature of cardiac lesions and raise the prospect of an autoimmune-type response that could contribute to the progressive remodeling and adverse function of myocardium that is seen in humans with chronic cardiac failure. ALDOmediated, Na ϩ -dependent efflux of Mg 2ϩ has been observed in cultured human lymphocytes, and lymphocyte [Mg 2ϩ ] i is reduced in patients with PAL (20). Yndestad et al. (74) found upregulated expression of a TNF family of ligands in the transcriptome of PBMCs obtained from patients with heart failure. Our findings not only broaden the concept of an immunoneuroendocrine interface (42), but they raise the intriguing prospect that information derived from the PBMC transcriptomes (as may also be the case for their proteomes) may serve as noninvasive biomarkers of disease risk, onset, and progression in human heart failure. This remains to be elucidated.
In summary, we conducted a detailed molecular characterization of PBMCs at 1 and 4 wks in a rat model of aldosteronism. On the basis of our findings, we propose a paradigm that is depicted in Fig. 6 
